BioCardia, Inc. and Symphony Medical, Inc. announce a mutually exclusive agreement for development and commercialization of a combination product that combines Symphony Medical's biotherapeutic technology and BioCardia device delivery technology for the treatment of cardiac conduction disorders.
As millions of Americans and people around the world continue to suffer from severe back pain, new technologies are emerging to bring relief to those in need of therapy. According to a new report by Millennium Research Group (MRG), the US market for spinal implants will grow by almost $2 billion over the next five years, reaching annual sales of $4.5 billion in 2009.
Infrared Saunas are sweeping the nation as the new best kept secret in personal care. As the baby boomer bubble moves across the time line, this generation is more aware of aging, health and other life impacting issues than ever before. With documented disease and illness at an all time high – this new technology offers something to everyone in the way of better health.
Insight Sciences, a biomedical imaging technology company, and the University of Michigan recently completed a license agreement that allows Insight Sciences to sell the FDA approved 4D-MSPECT Myocardial Perfusion and Function Imaging software package.
Purafil, the leading manufacturer of air filtration systems for removal of odors and gaseous pollutants, introduces a new, dry-scrubbing media that has a hydrogen sulfide removal capacity of 35 percent by weight (100 lbs of Odorcarb II media will remove 35 lbs of hydrogen sulfide gas).